Preview

Problems of Endocrinology

Advanced search

Mammographic breast density in postmenopausal women presenting with the disturbances of carbohydrate metabolism and metabolic syndrome

https://doi.org/10.14341/probl201258216-20

Abstract

Mammographic breast density (MBD) was determined visually in 51 postmenopausal women examined in the fasting state and after oral glucose level for obtaining their anthropometric and laboratory characteristics. The women presenting with impaired glucose tolerance/newly diagnosed diabetes mellitus (n=16) had the same MBD values as those having no such disorders (n=35). In the presence of the symptoms of metabolic syndrome, mammographic breast density tended to decrease to 16.5±4.3% in 17 women compared with 24.4±3.1% in 34 women without such symptoms. The diabetes risk score, unlike the blood glucose and reactive insulin levels, showed negative correlation with the MBD values. Such inverse relationship was especially pronounced in the women with the disturbances of carbohydrate metabolism and symptoms of metabolic syndrome. The inverse correlation between these characteristics and MBD values showed the strong dependence on the body mass index. It is concluded that parameters associated with impaired glucose tolerance and metabolic syndrome considered to be risk factors of the development of breast cancer are unrelated to increased mammographic breast density which suggests the difference in the mechanisms responsible for hormonal and metabolic predisposition to these pathologies.

References

1. Vachon C.M., van Gils C.H., Sellers T.A., Ghosh K., Pruthi S., Brandt K.R., Pankratz V.S. Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 2007; 9: 6: 217.

2. Boyd N.F., Martin L.J., Bronskill M., Yaffe M.J., Duric N., Minkin S. Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst 2010; 102: 16: 1224-1237.

3. Sellers T.A., Jensen L.E., Vierkant R.A., Fredericksen Z.S., Brandt K.R., Giuliano A.R., Pankratz V.S., Cerhan J.R., Vachon C.M. Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study. Cancer Causes Control 2007; 18: 5: 505-515.

4. Берштейн Л.М. Онкоэндокринология (традиции, современность и перспективы). СПб: Наука 2004; 343.

5. Cowey S., Hardy R.W. The metabolic syndrome: A high risk state for cancer? Am J Pathol 2006; 169: 1505-1522.

6. Boyd N.F., Byng J.W., Jong R.A., Fishell E.K., Little L.E., Miller A.B., Lockwood G.A., Tritchler D.L., Yaffe M.J. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995; 87: 9: 670-675.

7. Национальное руководство по эндокринологии. Под ред. И.И. Дедова, Г.А. Мельниченко. М 2009; 1064.

8. Lindstrom J., Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003; 26: 725-731.

9. Conroy S.M., Butler L.M., Harvey D., Gold E.B., Sternfeld B., Greendale G.A., Habel L.A. Metabolic syndrome and mammographic density. The study of women's health across the nation (SWAN). Int J Cancer 2010.

10. Boyd N.F., Martin L.J., Sun L., Guo H., Chiarelli A., Hislop G., Yaffe M., Minkin S. Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15: 11: 2086-2092.

11. Дрейпер Н., Смит Г. Прикладной регрессионный анализ. Множественная регрессия. Пер. с англ. 3-е изд. М: Диалектика 2007; 912.

12. Healy L.A., Ryan A.M., Carroll P., Ennis D., Crowley V., Boyle T., Kennedy M.J., Connolly E., Reynolds J.V. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol (R Coll Radiol) 2010; 22: 4: 281-288.

13. Roubidoux M.A., Kaur J.S., Griffith K.A., Sloan J., Wilson C., Novotny P., Lobell M. Correlates of mammogram density in southwestern Native-American women. Cancer Epidemiol Biomarkers Prev 2003; 12: 6: 552-558.

14. Calle E.E., Thun M.J. Obesity and cancer. Oncogene 2004; 23: 38: 6365-6378.

15. Берштейн Л.М. Бигуаниды: экспансия в практическую онкологию (прошлое и настоящее). СПб: Эскулап 2010; 144.

16. Дедов И.И., Бутрова С.А., Берковская М.А. Потенциальные возможности метформина в профилактике и лечении онкологических заболеваний у больных сахарным диабетом 2-го типа. Ожирение и метаболизм 2011; 1: 26: 40-50.


Review

For citations:


Bershteĭn L.M., Vasil'ev D.A., Poroshina T.E., Kovalenko I.G. Mammographic breast density in postmenopausal women presenting with the disturbances of carbohydrate metabolism and metabolic syndrome. Problems of Endocrinology. 2012;58(2):16-20. https://doi.org/10.14341/probl201258216-20

Views: 426


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)